Tricuspid Valve Interventions

From Fundamentals to Cutting-Edge Percutaneous Treatments
1. Auflage 2026
ISBN: 978-1-032-94179-0
Verlag: Taylor & Francis Ltd

Buch, Englisch, 256 Seiten, Format (B × H): 210 mm x 280 mm

Edited by

Francesco Maisano, MD, FESC, FHFA
Head of Cardiac Surgery and Director of the Valve Center, IRCCS San Raffaele Hospital, Milan, Italy

Fabien Praz, MD
Interventional Cardiologist and Associate Professor, Bern University Hospital, Switzerland

Marianna Adamo, MD, PhD
Interventional Cardiologist, Heart Failure Physician, and Associate Professor, University of Brescia, Italy

Roberto M. Lang, MD, FASE
Formerly Director of the Cardiac Noninvasive Imaging Laboratory and the A.J. Carlson Professor of Medicine, University of Chicago, Chicago, IL, USA

Yoshinobu Onuma, MD, PhD
Professor in Interventional Cardiology Medical Director, CORRIB Core Laboratory, University of Galway, Ireland

Tsung-Ying Tsai, MD, PhD
Clinical Scientist, Boston Scientific, Galway, Ireland

Martin B. Leon, MD
Director of the Center for Interventional Vascular Therapy, New York-Presbyterian/ Columbia University Irving Medical Center, New York, NY, USA

Patrick W. Serruys, MD, PhD, eFESC, FACC
Established Professor of Interventional Medicine and Innovation, NUI Galway Senior Consultant, CORRIB Research Centre for Advanced Imaging and Core Laboratory College of Medicine, Nursing and Health Sciences, University of Galway, Ireland

Associate Editors

Pruthvi T.C. Revaiah, MD, DM, PhD
CHIP Fellow at Icahn School of Medicine at Mount Sinai, New York, NY, USA

Aishwarya Gurav
Research Assistant, University of Galway, Ireland

Tricuspid Valve Regurgitation is a common valvular pathology, estimated to affect 1.6 million people in the US alone. Even though guidelines recommend either medical therapy or surgical treatment, the misconception of the disorder as a benign disease (along with the high mortality rates of surgical intervention) has led to undertreatment of this disease and description of it as a “forgotten” valve. This text from international experts looks at the disease and the developing transcatheter interventions with
promising potential for use in the clinical setting.

Zielgruppe

Professional Practice & Development

Autoren/Hrsg.

Maisano, Francesco

Praz, Fabien

Adamo, Marianna

Lang, Roberto M.

Onuma, Yoshinobu

Tsai, Tsung-Ying

Leon, Martin B.

Serruys, Patrick W.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Kardiologie, Angiologie, Phlebologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Innere Medizin
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Chirurgie Herz- & Thoraxchirurgie

Inhaltsverzeichnis

1. Introduction: Conquering tricuspid insufficiency, from diagnosis to therapy 2. The tricuspid valve: Anatomy, nomenclature, and pathology 3. Epidemiology of tricuspid valve disease: A growing burden 4. Pathophysiology of the tricuspid valve and the right heart disease 5. Clinicalpathways and clinical presentation 6. Etiology of tricuspid valve disease: Not one disease 7. Echocardiography in the management of tricuspid valve disease: Evaluation, screening selection, and procedural planning 8. Early diagnosis and monitoring of tricuspid regurgitation 9. Patient selection and risk stratification for tricuspid valve intervention/surgery 10. Cardiac computed tomography in the management of tricuspid valve disease 11. Right heart catheterization: A mandatory complement to non-invasive imaging 12. Medical management of tricuspid valve disease 13. Surgical treatment for tricuspid valve disease 14. The surgical correction of tricuspid valve disease 15. Introduction to transcatheter tricuspid valve intervention 16. Landscape of transcatheter treatment options and device selection 17. Transcatheter edge-to-edge repair 18. Transcatheter annular approaches for tricuspid regurgitation 19. Tricuspid valve interventions: Transcatheter tricuspid valve-in-valve and valve-in-ring 20. Intraprocedural imaging guidance including fluoroscopy, TEE, ICE, and fusion for transcatheter tricuspid valve interventions 21. Heterotopic caval valve implantation 22. Tricuspid valve interventions: From fundamentals to cutting-edge percutaneous treatments 23. Complications of transcatheter tricuspid valve replacement and management strategies  24. Emerging technologies 25. Closing remarks and future perspectives: A long journey, and still a road ahead Appendix. Index.

Über Autor(innen)

Francesco Maisano, MD, FESC, FHFA
Head of Cardiac Surgery and Director of the Valve Center, IRCCS San Raffaele Hospital, Milan, Italy

Fabien Praz, MD
Interventional Cardiologist and Associate Professor, Bern University Hospital, Switzerland

Marianna Adamo, MD, PhD
Interventional Cardiologist, Heart Failure Physician, and Associate Professor, University of Brescia, Italy

Roberto M. Lang, MD, FASE
Formerly Director of the Cardiac Noninvasive Imaging Laboratory and the A.J. Carlson Professor of Medicine, University of Chicago, Chicago, IL, USA

Yoshinobu Onuma, MD, PhD
Professor in Interventional Cardiology Medical Director, CORRIB Core Laboratory, University of Galway, Ireland

Tsung-Ying Tsai, MD, PhD
Clinical Scientist, Boston Scientific, Galway, Ireland

Martin B. Leon, MD
Director of the Center for Interventional Vascular Therapy, New York-Presbyterian/ Columbia University Irving Medical Center, New York, NY, USA

Patrick W. Serruys, MD, PhD, eFESC, FACC
Established Professor of Interventional Medicine and Innovation, NUI Galway Senior Consultant, CORRIB Research Centre for Advanced Imaging and Core Laboratory College of Medicine, Nursing and Health Sciences, University of Galway, Ireland

Associate Editors

Pruthvi T.C. Revaiah, MD, DM, PhD
CHIP Fellow at Icahn School of Medicine at Mount Sinai, New York, NY, USA

Aishwarya Gurav
Research Assistant, University of Galway, Ireland